4Dcell (“4Dcell”), a French biotechnology company pioneering innovative in vitro models and New Approach Methodologies (NAMs) for drug discovery and toxicology, announced today the company will participate at Nordic Life Science Days (NLSDays) on October 13-14, 2025, in Gothenburg, Sweden.
4Dcell’s flagship SmartHeart platform delivers an easy-to-use 3D cardiac model that enables pharmaceutical companies, biotechs, and CROs to assess both drug efficacy and cardiotoxicity with unprecedented precision. The platform’s innovative ring-shaped cardiac tissues, developed in collaboration with INSERM’s Paris Cardiovascular Research Center, provide high-throughput screening capabilities while requiring minimal cells and delivering reproducible results that closely replicate in vivo physiology.
“We’re excited to be part of NLSDays and connect with the Nordic life science community, from pharma and biotech innovators to CROs and investors. The event is a key opportunity to showcase how our SmartHeart platform is redefining preclinical cardiac safety and efficacy testing. By delivering more predictive data, accelerating development timelines, and removing the need for animal testing, SmartHeart addresses one of the industry’s most pressing challenges. We look forward to engaging with partners who share our vision for next-generation drug development,” said Cyril Cerveau, CEO of 4Dcell.
The company’s participation at NLSDays follows its recent selection for the EIC Corporate Day, where 4Dcell will showcase its breakthrough cardiac NAMs technology to leading pharmaceutical innovators. This recognition by the European Innovation Council underscores the growing industry demand for more predictive, ethical alternatives to traditional preclinical testing methods.
To schedule a meeting with 4Dcell, register at: https://nlsdays.com/partnering/.
NLSDays is the premier Nordic life science partnering event, bringing together industry leaders, investors, and innovators from across the globe. The two-day conference in Gothenburg features company presentations, partnering meetings, and networking opportunities within the region’s thriving biotech sector.
